Neumora Therapeutics, Inc.
NMRA • NASDAQ
Neumora Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daljit Singh Aurora, with a market cap of $396.0M.
CEODaljit Singh Aurora
Next Earnings
Upcoming earnings announcement for Neumora Therapeutics, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.32
Earnings History
Past 9 earnings reports for Neumora Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Q3 2025 | -$0.35Est: -$0.34 | -2.9% | - | — |  10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.33Est: -$0.37 | +10.8% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.42Est: -$0.38 | -10.5% | - | — | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$0.37Est: -$0.37 | 0.0% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.45Est: -$0.39 | -15.4% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.37Est: -$0.37 | 0.0% | - | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.34Est: -$0.34 | 0.0% | - | — | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.71Est: -$0.55 | -29.1% | - | — | 10-K |
| Nov 1, 2023 | Q3 2023 | -$1.14Est: -$0.36 | -216.7% | - | — | — |